Sara-Bay Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Sell
906
-66
-7% -$24.5K 0.09% 68
2026
Q1
$285K Sell
972
-100
-9% -$32.9K 0.09% 68
2025
Q4
$374K Hold
1,072
0.11% 61
2025
Q3
$346K Sell
1,072
-30
-3% -$9.33K 0.1% 63
2025
Q2
$429K Hold
1,102
0.15% 55
2025
Q1
$476K Hold
1,102
0.21% 52
2024
Q4
$406K Sell
1,102
-350
-24% -$146K 0.15% 63
2024
Q3
$755K Buy
+1,452
New +$776K 0.27% 40

Other funds holding ELV

Sara-Bay Financial's ELV Position: Q2 2026 in Review

Sara-Bay Financial reduced its Elevance Health (ELV) stake by 6.8% in Q2 2026, selling an estimated $24.5K and leaving 906 shares worth $350K. The position accounts for 0.09% of the portfolio, ranked #68.

Sara-Bay Financial first reported a position in ELV in Q3 2024 and has held it in 8 quarters since. The position peaked at $755K in Q3 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sara-Bay Financial held 906 shares of Elevance Health worth $350K as of Q2 2026.
  • Sara-Bay Financial sold 66 Elevance Health shares in Q2 2026, an estimated $24.5K.
  • Elevance Health made up 0.09% of Sara-Bay Financial's portfolio in Q2 2026, its #68 holding.
  • Sara-Bay Financial first reported a position in Elevance Health in Q3 2024 and has held it in 8 quarters since.
  • Sara-Bay Financial's Elevance Health position peaked at $755K in Q3 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sara-Bay Financial's 13F filing for Q2 2026, filed 17 Jul 2026.